A bipartisan group of House Energy and Commerce Committee members want information from FDA on complex generic approvals, potentially to consider ways of streamlining the process.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
